Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial. [PDF]
Liu X +9 more
europepmc +1 more source
Critical appraisal of the literature reporting association between measles-mumps-rubella vaccine and autism [PDF]
Καραΐσκου, Μαριάνθη
core +1 more source
APHL/CDC Vaccine preventable disease reference centers : a year in review : April 2013-June 2014 [PDF]
Vaccines are one of the most effective public health interventions that has ever been employed. Routine use of vaccines has significantly reduced or eliminated many previously common childhood vaccine preventable diseases (VPDs) in the US.
core
Meningoencephalitis after measles-mumps-rubella vaccine. [PDF]
M E Ramsay, M Rao
openaire +1 more source
Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc +1 more source
Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]
Ratta BS, Naik A, Mutha S.
europepmc +1 more source
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine. [PDF]
Crooke SN +4 more
europepmc +1 more source
A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc +1 more source
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]
Saha S +11 more
europepmc +1 more source

